|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/0783 | |
| A61K 35/50 | |||
| A61P 35/00 | |||
| A61K 35/12 |
| (11) | Patento numeris | 2411506 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10722830.6 |
| Europos patento paraiškos padavimo data | 2010-03-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/028885 |
| Data | 2010-03-26 |
| (87) | Numeris | WO 2010/111631 |
| Data | 2010-09-30 |
| (30) | Numeris | Data | Šalis |
| 163449 P | 2009-03-25 | US |
| (72) |
ZHANG, Xiaokui, US
KANG, Lin, US
HEIDARAN, Mohammad, US
JASKO, Steven, US
ZEITLIN, Andy, US
PAL, Ajai, US
HARIRI, Robert, J., US
|
| (73) |
Celularity, Inc.,
33 Technology Drive, Warren, NJ 07059,
US
|
| (54) | TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS |
| TUMOR SUPPRESSION USING HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS |